Trialect

+ More Filters

Reset Filters

Specialty

Funding Organization

Funding Type

Eligible Country

Deadline

From

Other (Select all that apply)

Show Expired Programs

Show Verified Programs

Verified

Established Investigator Award

American Heart Association

Purpose

To support established investigators at the associate professor level, who are in a rapid growth phase of their career, have established records of accomplishments and continue to show extraordinary promise.
The investigator’s career is expected to clearly benefit from the EIA award.
Candidates will have a demonstrated commitment to cardiovascular or cerebrovascular science disciplines that support the AHA’s mission to be a relentless force for a world of longer, healthier lives, as indicated by funding and publication history and scientific accomplishments.
Candidates should propose an innovative\novel research direction that challenges existing paradigms and employs novel concepts, approaches, or technologies.

Mandatory Pre-proposal

Each Established Investigator Award applicant is required to submit a pre-proposal and other items listed below via ProposalCentral on or before Wednesday, October 2, 2024, at 3 p.m. CT.

Applicants must be AHA Professional Members.

AHA will contact applicants with the highest-rated pre-proposals and invite them to submit a full application.

Submit the following documents:

A pre-proposal (2-page limit) that briefly describes the investigator's competitiveness in terms of:
- Demonstrated commitment to the study of cardiovascular and/or cerebrovascular disease and scientific innovation.
- Independence as assessed by publications, research funding, and impact of scientific work as a principal investigator.
- How the award will enhance the investigator's rapid career growth phase.
A list of the applicant's 15 most impactful and/or foundational publications that are relevant to the proposed research focus or this program in a .PDF document. When selecting, consider those which are foundational papers that support your research program; those that are most cited; and for more recent publications, those in the most high-impact journals or that you predict will elicit the most citations. (2-page limit)
A document that details the PI's last five years of research funding (1-page limit)
NIH biosketch (5-page limit)

Applicants are also required to complete the following sections in ProposalCentral:

Project Summary - Write a concise description or abstract describing the work proposed. This should be as brief as possible, since you also will be required to upload a separate LOI document. Note: This field will not accept any special characters or keystrokes (e.g., β, π, etc.).
Non-Scientist Summary - Enter a description of your project that is written to be understood by non-scientists. This information may be reviewed by people who do not have scientific or medical backgrounds. Be clear and avoid technical and scientific terms, when possible. When formulating your lay summary, it might help to imagine that you are explaining your work to a new acquaintance who does not work in the science field. NOTE: It is incumbent upon the applicant to make a clear link between the project and the mission of the AHA.

No reference letters are to be supplied with the initial LOI. Three references will be required from those selected to submit a full application.

Abbreviated Proposal

The Established Investigator Award invited proposal is limited to eight (8) pages and should:

describe and summarize past research accomplishments,
outline the impact of the investigator’s previous research accomplishments,
demonstrate the potential of the EIA to provide new directions and innovations beyond that covered by other current funding,
clarify how this proposal differs from other funded projects, or how these funds will be used to expand upon other projects,
explain how this award will contribute to the applicant’s rapid career growth and the potential for significant impact to the AHA mission, and
broadly discuss projected research directions that would be pursued with the EIA.

The proposal should not contain detailed protocols or focus heavily on the design or interpretation of individual experiments.

Budget

Award: $110,000 per year, including 10 percent indirect costs (Indirect costs are not to exceed $11,000 per year)

Aside from the cap on indirect costs, there is no limit on budget categories. Funds may be used as the principal investigator deems necessary, in accordance with institutional and AHA policies. AHA does not require use of the NIH salary cap.

Budget items may include:

salary and fringe of the principal investigator, any collaborating investigators, and other participants with faculty appointments
salaries of technical personnel essential to the conduct of the project
supplies
equipment
travel
volunteer subject costs
data management
publication costs

While no specific minimum effort is required for the EIA program, the time committed should align with the proposed project. Special consultative services from individuals may be requested, provided the circumstances are fully described in the application. International travel is permitted without prior AHA approval.

Award Duration: Five years; non-renewable

Maximum Award Amount: $550,000

Restrictions

Past EIA awardees are not eligible to reapply to this mechanism nor submit more than one proposal per cycle.
An EIA awardee may hold an additional AHA research grant, such as a Strategically Focused Research Project, IPA, or TPA, but may not hold a career development/recognition award at the same time (i.e. Career Development Award or Merit Award).

Peer Review Criteria for Established Investigator Award

Applicants should never contact reviewers regarding their applications. Discussing the content of an application or attempting to influence review outcome will constitute a conflict of interest in the review. Reviewers must notify the AHA if an applicant contacts them.

To judge the merit of the application, reviewers will comment on the following criteria. Fully address these in your proposal.

Generally, the candidate and the innovativeness of the proposal are being evaluated. The first two of the following criteria must be met to be competitive. The remaining factors enter into deliberations, but the relative weight given to each may differ from case to case.

1. Innovative, novel research direction described in the abbreviated application. Is the research direction described by the candidate likely to lead to significant contributions? Does the candidate pose an innovative research direction that challenges existing paradigms or critical barriers to progress in the field? Does the candidate propose to develop or employ novel concepts, approaches or technologies? Does this research direction address an important barrier to achieving a world of longer, healthier lives?

2. Applicant's demonstrated commitment to cardiovascular or cerebrovascular diseases: Has the research program of the candidate focused on the impact of basic or applied science to cardiovascular or cerebrovascular disease? Does the applicant indicate a clear commitment to cardiovascular/cerebrovascular research in the proposed studies? Do the proposed studies illustrate this commitment?

3. Investigator Independence: Independence is assessed by publications and financial support as a principal investigator. Is the candidate established as an independent investigator?

4. Investigator potential: The investigator's potential for career growth should be assessed by several factors. These include the applicant's number, quality and independence of publications in peer-reviewed journals, previous professional accomplishments, and relevant experience. Do the reference letters and department head letter support the conclusion that the candidate's career is in a rapid growth phase? Is it likely that the investigator will have an impact on the field?

5. Prior and current independent national-level funding: Does the candidate's track record of funding provide evidence of independence? Does the candidate’s current funding demonstrate a rapid phase of growth? Has the candidate held independent national awards, such as an NIH R01 and/or equivalent? (e.g., VA Merit Award, NSF Grant, or PI of a project on a Program Project Grant from NIH). NIH "K" series awards are not considered equivalent to R01. Note: To encourage submissions from clinical investigators, epidemiologists, and translational scientists, individuals with significant funding support from national-level peer reviewed clinical and multicenter trials and/or other clinically oriented grants will be considered (e.g., U01, UL1, and equivalent awards).

6. Award impact on career development: Impact should be assessed based on the letters from the department head and references. Is it clear that the award will propel the career development of the candidate?

7. Environment: Does the environment in which the work will be done contribute to the probability of success? Does the proposal benefit from unique features of the scientific environment, or subject populations, or employ useful collaborative arrangements? Is there evidence of institutional support?

8. Impact: Applications for research funding will be assessed for their potential impact on the AHA Mission, and on the applicant’s ability to effectively describe the proposal and its potential outcomes to non-scientists. This potential impact assessment will be based primarily on the Summary for Non-scientists. This assessment will be factored into the Impact peer review criterion, which will account for 5-10% of the overall priority score.

Specialties

Cardiovascular Diseases

Eligibility Requirements

At the time of application, must have:

MD, PhD, DO, DVM, or equivalent doctoral degree
Full-time faculty/staff scientist position or equivalent.
NOTE: At the time of award activation must have an appointment at the ASSOCIATE PROFESSOR LEVEL or equivalent (including, but not limited to, research associate professor, research scientist, staff scientist, etc.) and be no more than 15 years since first faculty appointment.
History and current evidence of substantial extramural funding

Sponsor Details

Sponsor Institute/Organizations: American Heart Association

Address: National Center 7272 Greenville Ave. Dallas, TX 75231 Customer Service 1-800-AHA-USA-1 1-800-242-8721

Legal & Affiliation Disclaimer

Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.

Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.

Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.

Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.

Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.

Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.

Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.

View Funding Opportunity